Cargando…

Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid

Blood sampling to assess production of antigen-specific antibodies after immunization is commonly performed, but it presents logistical difficulties for trials carried out during an infectious disease outbreak. In this study, we show that antibodies may be reliably detected in oral fluid collected i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lambe, Teresa, Rampling, Tommy, Samuel, Dhan, Bowyer, Georgina, Ewer, Katie J., Venkatraman, Navin, Edmans, Matthew, Dicks, Steve, Hill, Adrian V. S., Tedder, Richard S., Gilbert, Sarah C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4796941/ https://www.ncbi.nlm.nih.gov/pubmed/27004234 http://dx.doi.org/10.1093/ofid/ofw031

Ejemplares similares

Reduced Ebola vaccine responses in CMV(+) young adults is associated with expansion of CD57(+)KLRG1(+) T cells
por: Bowyer, Georgina, et al.
Publicado: (2020)

CXCR3(+) T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria
por: Bowyer, Georgina, et al.
Publicado: (2018)

A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines?
por: Lambe, Teresa, et al.
Publicado: (2017)

Activation-induced Markers Detect Vaccine-Specific CD4(+) T Cell Responses Not Measured by Assays Conventionally Used in Clinical Trials
por: Bowyer, Georgina, et al.
Publicado: (2018)

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal
por: Venkatraman, Navin, et al.
Publicado: (2019)

Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014–2016: A cross-sectional study
por: Houlihan, Catherine F., et al.
Publicado: (2017)

Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
por: Powlson, Jonathan, et al.
Publicado: (2019)

Chimpanzee adenoviral vectors as vaccines for outbreak pathogens
por: Ewer, Katie, et al.
Publicado: (2017)

Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01(B) With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP
por: Rampling, Tommy, et al.
Publicado: (2016)

CMV-associated T cell and NK cell terminal differentiation does not affect immunogenicity of ChAdOx1 vaccination
por: Sharpe, Hannah R., et al.
Publicado: (2022)

Generation and Characterisation of Monoclonal Antibodies against Nairobi Sheep Disease Virus Nucleoprotein
por: Maze, Emmanuel A., et al.
Publicado: (2023)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Ebola virus antibody decay–stimulation in a high proportion of survivors
por: Adaken, Charlene, et al.
Publicado: (2021)

Clinical Evaluation of QuickNavi(TM)-Ebola in the 2018 Outbreak of Ebola Virus Disease in the Democratic Republic of the Congo
por: Makiala, Sheila, et al.
Publicado: (2019)

An in vitro assay to measure antibody-mediated inhibition of P. berghei sporozoite invasion against P. falciparum antigens
por: Rodríguez-Galán, Ana, et al.
Publicado: (2017)

Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals
por: Hodgson, Susanne H., et al.
Publicado: (2015)

Survivors of Ebola Virus Disease Develop Polyfunctional Antibody Responses
por: Gunn, Bronwyn M, et al.
Publicado: (2020)

Clinical Assessment of a Novel Recombinant Simian Adenovirus ChAdOx1 as a Vectored Vaccine Expressing Conserved Influenza A Antigens
por: Antrobus, Richard D, et al.
Publicado: (2014)

Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
por: Bliss, Carly M., et al.
Publicado: (2018)

Added Value of an Anti-Ebola Serology for the Management of Clinically Suspected Ebola Virus Disease Patients Discharged as Negative in an Epidemic Context
por: Nkuba-Ndaye, Antoine, et al.
Publicado: (2022)

Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days
por: Diallo, Boubacar, et al.
Publicado: (2016)

Antibody-Dependent Natural Killer Cell Activation After Ebola Vaccination
por: Wagstaffe, Helen R, et al.
Publicado: (2019)

The Cytokine Response Profile of Ebola Virus Disease in a Large Cohort of Rhesus Macaques Treated With Monoclonal Antibodies
por: Banadyga, Logan, et al.
Publicado: (2019)

IDSA Ebola Summary—August 2014
por: Murray, Barbara E., et al.
Publicado: (2014)

Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy
por: Marks, Michael, et al.
Publicado: (2020)

Risk in the “Red Zone”: Outcomes for Children Admitted to Ebola Holding Units in Sierra Leone Without Ebola Virus Disease
por: Fitzgerald, F, et al.
Publicado: (2017)

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored malaria vaccine candidate in 5-17 months old infants and children
por: Tiono, Alfred B., et al.
Publicado: (2018)

Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP
por: Rampling, Tommy, et al.
Publicado: (2018)

Ebola Virus Ribonucleic Acid Detection in Semen More Than Two Years After Resolution of Acute Ebola Virus Infection
por: Fischer, William A, et al.
Publicado: (2017)

Safety and Immunogenicity of Adenovirus and Poxvirus Vectored Vaccines against a Mycobacterium Avium Complex Subspecies
por: Folegatti, Pedro M., et al.
Publicado: (2021)

Comprehensive Clinical and Laboratory Follow-up of a Female Patient With Ebola Virus Disease: Sierra Leone Ebola Virus Persistence Study
por: Liu, William J, et al.
Publicado: (2019)

Potent CD8(+) T-Cell Immunogenicity in Humans of a Novel Heterosubtypic Influenza A Vaccine, MVA−NP+M1
por: Berthoud, Tamara K., et al.
Publicado: (2011)

End of the Ebola virus outbreak: time to reinforce the African health system and improve preparedness capacity
por: Mulinge, Ivy, et al.
Publicado: (2016)

The early landscape of coronavirus disease 2019 vaccine development in the UK and rest of the world
por: Sharpe, Hannah R., et al.
Publicado: (2020)

Ebola Hemorrhagic Fever and the Current State of Vaccine Development
por: Hong, Joo Eun, et al.
Publicado: (2014)

Identification of a New Ribonucleoside Inhibitor of Ebola Virus Replication
por: Reynard, Olivier, et al.
Publicado: (2015)

Dilemmas in Managing Pregnant Women With Ebola: 2 Case Reports
por: Caluwaerts, Séverine, et al.
Publicado: (2016)

Inhibition of in vitro Ebola infection by anti-parasitic quinoline derivatives
por: Goyal, Shawn, et al.
Publicado: (2020)

Cerebrospinal Fluid Aquaporin-4 Antibody Levels in Neuromyelitis Optica Attacks
por: Sato, Douglas Kazutoshi, et al.
Publicado: (2014)

Evaluation of antibodies in cerebrospinal fluid for the diagnosis of tick-borne encephalitis in dogs
por: Alnefelt, Yvonne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d3cncjmf8le78uvs9ls7538l11